These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution. Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321 [TBL] [Abstract][Full Text] [Related]
5. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510 [TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction. Raja SG Ann Thorac Surg; 2006 Mar; 81(3):1162-71. PubMed ID: 16488758 [TBL] [Abstract][Full Text] [Related]
8. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Guyton RA Ann Thorac Surg; 2006 Jun; 81(6):1949-57. PubMed ID: 16731112 [TBL] [Abstract][Full Text] [Related]
9. Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials. Biondi-Zoccai GG; Abbate A; Agostoni P; Parisi Q; Turri M; Anselmi M; Vassanelli C; Zardini P; Biasucci LM Ital Heart J; 2003 Apr; 4(4):271-80. PubMed ID: 12784781 [TBL] [Abstract][Full Text] [Related]
10. Three years after SYNTAX trial--change in practice? Rastan AJ; Mohr FW Eur J Cardiothorac Surg; 2011 Dec; 40(6):1279-81. PubMed ID: 21982122 [No Abstract] [Full Text] [Related]
11. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
12. Design of the 'Stent or Surgery' trial (SoS): a randomized controlled trial to compare coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multi-vessel coronary artery disease. Stables RH Semin Interv Cardiol; 1999 Dec; 4(4):201-7. PubMed ID: 10738353 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734 [TBL] [Abstract][Full Text] [Related]
14. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Ong AT; Serruys PW; Mohr FW; Morice MC; Kappetein AP; Holmes DR; Mack MJ; van den Brand M; Morel MA; van Es GA; Kleijne J; Koglin J; Russell ME Am Heart J; 2006 Jun; 151(6):1194-204. PubMed ID: 16781219 [TBL] [Abstract][Full Text] [Related]
15. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]. Silber S; Herdeg C Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314 [TBL] [Abstract][Full Text] [Related]
16. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'. Jeremias A; Ruisi CP; Kirtane AJ; Lee T; Sylvia B; Pinto DS; Ho KK; Cutlip DE; Carrozza JP; Cohen DJ Coron Artery Dis; 2008 Mar; 19(2):111-5. PubMed ID: 18300748 [TBL] [Abstract][Full Text] [Related]
17. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. Nikolsky E; Lansky AJ; Sudhir K; Doostzadeh J; Cutlip DE; Piana R; Su X; White R; Simonton CA; Stone GW Am Heart J; 2009 Oct; 158(4):520-526.e2. PubMed ID: 19781409 [TBL] [Abstract][Full Text] [Related]
18. The design, patient population and outcomes from the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registries. Brooks MM; Detre KM Semin Interv Cardiol; 1999 Dec; 4(4):191-9. PubMed ID: 10738352 [TBL] [Abstract][Full Text] [Related]